The Glaucoma Research Foundation (GRF) named Dennis Singleton the 2009 recipient of its Visionary Award. As a long-time member of the GRF’s board, Mr. Singleton was honored for his dedication to the cause of glaucoma research and education.
According to a news release, Mr. Singleton has served on the GRF’s board of directors since 1998 and served as board chairman from July 2003 to June 2006. Under his leadership, the GRF reportedly realized its greatest growth in contributed income, and its Catalyst for a Cure Campaign raised $8.6 million to support glaucoma research.
“[Mr. Singleton’s] leadership provided a wonderful opportunity to learn from him and work together toward a greater vision for the GRF,” said Thomas M. Brunner, president and chief executive officer of the GRF, in a news release.
Click here for more industry news and clinical trial updates.
TOP 5 ARTICLES FROM 2010
- Bleb Revision
Glaucoma Today asked three surgeons when they revise a bleb.
By Karen Joos, MD, PHD; Jonathan S. Myers, MD; and Barbara Smit, MD, PHD
- Trabeculectomy Revision as a Treatment for Failed Trabeculectomy
By Nathan M. Radcliffe, MD
- Vision Loss After Trabeculectomy in Advanced Glaucoma
By Nils A. Loewen, MD, PHD
- Technologies for Analyzing the Optic Disc, RNFL, and Macula
By Victor Y. Chang, MD, Terry Kim, MD, Neil T. Choplin, MD, and Paul H. Artes, PhD
- Hushed No More
Tom Harbin, MD, opens the lid on a morass that injured patients, decimated careers, and shook the ophthalmology department of one of the most prestigious medical centers in the United States.
By Gillian McDermott, MA, Editor-In-Chief
Sides Media